The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visceral fat

På svenska

Author

  • J. Jendle
  • M. A. Nauck
  • D. Matthews
  • Anders Frid
  • K. Hermansen
  • M. During
  • M. Zdravkovic
  • B. Strauss
  • A. Garber

Publishing year

2008

Language

English

Pages

318-318

Publication/Series

Diabetologia

Volume

51

Issue

S1

Document type

Conference paper: abstract

Publisher

Springer

Topic

  • Endocrinology and Diabetes

Conference name

44th EASD Annual Meeting of the European Association for the Study of Diabetes

Conference date

2008-09-08 - 2008-09-11

Conference place

Rome, Italy

Status

Published

ISBN/ISSN/Other

  • ISSN: 1432-0428